Elevance Health is one of the largest health insurers in the United States, serving approximately 45.2 million medical members as of December 31, 2025. The company makes money in three main ways. First, it collects monthly premiums from individuals, employers, and government programs like Medicare and Medicaid. Second, it charges service fees to large employers who manage their own health costs but hire Elevance to process claims and run their networks. Third, through its Carelon business, it sells pharmacy services, behavioral health programs, and data analytics to both its own health plans and outside customers. The core of the model is a timing bet: Elevance collects premiums upfront, then pays medical bills later. If it predicts costs correctly, the gap between what it collects and what it pays out is profit. The diagram below traces where the money goes.
How Elevance Health Makes Money
flowchart TD
A["Members Enroll
45.2M medical"] --> B["Risk-Based Premiums
24.5B product revenue"]
A --> C["Fee-Based Services
8.5B service fees"]
B --> D["Medical Claims &
Cost Management"]
C --> D
D --> E["Provider Networks &
Care Coordination"]
E --> F["Clinical Quality
Outcomes Improve"]
F --> A
B --> G["CarelonRx Pharmacy
Services Revenue"]
C --> H["Carelon Services
Behavioral & Care"]
G --> E
H --> E
D --> I["Operating Cash Flow
4.3B annually"]
I --> J["Reinvest in
Networks & Tech"]
J --> E
Five years of financial data tell a story of a company growing its top line while its cash generation quietly shrinks. Revenue climbed steadily from 2021 through 2025. But revenue alone does not tell you how healthy a business is. The more important question is how much cash the business actually produces after paying all its bills.
Operating Cash Flow (2021 to 2025, $B)
Operating cash flow has fallen nearly in half over five years, from $8.4B in 2021 to $4.3B in 2025, even as revenue grew.
Operating cash flow dropped from $8.4 billion in 2021 to $4.3 billion in 2025. Free cash flow, which is the cash left over after the company spends money on equipment and technology, fell from $7.3 billion in 2021 to $3.2 billion in 2025. That is a significant decline. At the same time, net debt grew from $18.2 billion to $22.6 billion over the same period. The company is generating less cash while carrying more debt. The 10-K explains part of this: a large legal settlement payment in 2025, unfavorable working capital shifts, and lower net income in the Health Benefits segment all weighed on cash. But the underlying pressure is medical costs rising faster than premiums.
$3.2B
Free cash flow in 2025, down from $7.3B in 2021
What is a Medical Loss Ratio?
A medical loss ratio is the share of every premium dollar that gets paid out as medical claims. If a health insurer collects $100 in premiums and pays $87 in medical bills, its medical loss ratio is 87%. A rising ratio means costs are eating more of each dollar collected. Insurers set premiums months before they know what claims will actually cost, so if costs spike unexpectedly, the ratio rises and profit shrinks.
The gross margin data from the financials shows exactly this pressure. Gross margin fell from 41.9% in 2022 to 35.7% in 2025. That means for every dollar of revenue, the company is keeping fewer cents after paying its core costs. The company's own 10-K explains why: membership shifted from Medicaid into individual ACA plans after Medicaid redeterminations began in 2023. Those individual plan members turned out to be sicker than expected, driving up claims. Medicaid itself also saw higher costs due to increased utilization. Both trends squeezed margins at the same time.
Margin compression over three years reflects medical costs rising faster than premium rates.
Shareholders' net income for 2025 was $5.662 billion, a decrease of $318 million from 2024. Earnings per share fell from $25.68 to $25.21. The company attributed the drop primarily to lower operating performance in its Health Benefits segment. Revenue did grow to $197.6 billion in total operating revenue for 2025, a 12.8% increase, driven by premium rate increases and recent acquisitions. But growth in revenue did not translate into growth in profit or cash.
2023
crisis
Medicaid Redeterminations Trigger a Cost Spiral
Starting April 2023, states began removing people from Medicaid who no longer qualified, a process called redetermination. Many of those members moved into individual ACA marketplace plans instead. The problem: those new ACA members turned out to be sicker than the typical individual plan member. This drove up medical costs across the individual market, which Elevance had not fully priced into its premiums. The company's own filings describe this as a driver of elevated medical cost trends that continued through 2025.
The risk picture at Elevance Health is specific and documented. The company lists five high-severity risks in its filings, and each one connects directly to the core business model. The first is government payment rates. Roughly 32% of total consolidated revenues in 2025 came from U.S. government agencies. If Medicare or Medicaid payment rates do not keep pace with actual medical costs, the company absorbs the difference. It cannot raise prices mid-contract to compensate.
32%
Share of 2025 revenues from U.S. government agencies
The second risk is cost prediction failure. Premiums are locked in for twelve months at a time. If medical costs run higher than forecast during that period, Elevance pays the overage out of its own pocket. The third risk involves Medicare Advantage star ratings. The U.S. Centers for Medicare and Medicaid Services scores Medicare Advantage plans on a one-to-five star scale. Plans must score 4.0 stars or higher to receive bonus payments and to enroll new members year-round. As of the 2025 ratings cycle, approximately 40% of Elevance's Medicare Advantage members were in plans rated 4.0 stars or higher. The 2026 ratings improved that figure to approximately 59%, but the system changes every year and future ratings are not guaranteed. The fourth risk is audit clawbacks. The government runs audits of the health data that insurers submit to determine payment amounts. If the data is found inaccurate, the insurer must return previously received payments. CMS announced in May 2025 that it plans to substantially increase the scale and pace of these audits. The fifth risk is cybersecurity. Elevance holds sensitive health data on tens of millions of people. A breach could trigger large fines and lawsuits under federal and state privacy laws.
In 2025, subsidiaries of Elevance Health were sued in New York and Connecticut over alleged 'ghost networks,' which are provider directories that list doctors and hospitals the plan does not actually have access to. These cases add legal uncertainty on top of the existing regulatory pressure.
Elevance is also building out Carelon, its health services arm, as a second growth engine beyond traditional insurance. Carelon includes CarelonRx for pharmacy services, Carelon Health for home-based and virtual care, and Carelon Insights for data and analytics. The idea is to sell these services not just to Elevance's own health plan members but to outside customers too. The company completed several acquisitions to build this out, including CareBridge at the end of 2024, which manages home and community-based services for complex Medicaid and Medicare patients. Whether Carelon can become a meaningful, independent revenue source is still an open question.
What is Medicare Advantage?
Medicare Advantage is a version of Medicare run by private insurance companies instead of the federal government. People aged 65 and older can choose a Medicare Advantage plan as an alternative to standard government Medicare. The insurance company receives a fixed payment from the government per member per month, then covers that member's medical costs. If the member uses less care than expected, the insurer keeps the difference. If more, the insurer absorbs the loss.
Medicare Advantage is one of Elevance's growth areas. Medicare membership as a share of total medical members grew from 6.3% in 2023 to 6.9% in 2025. The company expanded its Medicare Advantage footprint into select service areas in Florida, Maryland, and Texas in 2025 through its Simply Healthcare and Wellpoint brands. But Medicare Advantage is also where the star ratings risk and the audit risk are most concentrated. The government's announced increase in audit activity lands squarely on this segment.
45.2M
Medical members served as of December 31, 2025
The Bet
Elevance can raise premiums fast enough, and accurately enough, to stay ahead of rising medical costs across its Medicare Advantage, Medicaid, and individual ACA businesses at the same time. If the company's actuaries can correctly predict what its members will spend on healthcare one year in advance, the margin compression of 2023 through 2025 stabilizes and the cash flow decline reverses. If medical cost trends continue to outrun premium increases, or if government payment rates for Medicare and Medicaid fall short of actual costs, the gap between revenue growth and cash generation widens further, and the debt load of $22.6 billion becomes harder to manage.
Open question
Elevance Health serves 45.2 million members, collects premiums from governments and employers at scale, and is building a services business in Carelon that could reduce dependence on pure insurance margins. But free cash flow has fallen from $7.3 billion to $3.2 billion in four years, net debt has grown to $22.6 billion, and the medical cost trends driving that compression have not yet fully resolved. The One Big Beautiful Bill Act signed in July 2025 adds new uncertainty around Medicaid enrollment, which is itself already shrinking due to redeterminations. Can Elevance reprice its way back to the cash generation levels it had in 2021, or have structural shifts in who its members are and what they cost made that level of profitability genuinely harder to reach?
Compiled · 10-K · FY2025
Medicare and Medicaid Payment Risk
The federal government and state governments set payment rates for Medicare and Medicaid programs, and these rates may not keep pace with the company's actual costs. If rates are cut, frozen, or payments are delayed, the company cannot quickly raise prices to recover losses since these contracts are fixed for extended periods.
Healthcare Cost Prediction Failure
The company must predict future medical costs months in advance to set prices, but actual costs often differ from predictions. Since premiums are locked for 12 months, if real costs exceed projections, the company absorbs the loss and cannot raise prices to compensate.
Star Ratings and Bonus Payment Risk
Medicare Advantage plans are rated on a star system that determines bonus payments and the ability to enroll new members year-round. The rating system changes frequently, making it difficult to predict future ratings, and lower ratings directly reduce revenue and membership growth.
Data Accuracy and Compliance Audits
CMS conducts audits (called RADV audits) of diagnostic data submitted by the company to determine payment amounts. If the company's data is found inaccurate, it must return previously received payments, and the company faces fines, penalties, or loss of ability to enroll new members.
Cybersecurity and Data Breach Liability
The company collects sensitive health and personal information regulated by HIPAA, state privacy laws, and international regulations like GDPR. A data breach could expose the company to large fines, lawsuits, loss of customers, and regulatory penalties under federal and state laws.
10-K Item 1A · Risk Factors
